KIR2DS4 and type 1 diabetes mellitus: Under model A.1, the A*03:01–KIR2DS4 interaction was found to negatively associate with progression to type 1 diabetes (HR 0.36, p=0.03) for 88 participants with disease with the interaction and 167 disease-free participants.